Stockreport

Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds [Seeking Alpha]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF Recent FDA draft guidance allowing MRD negativity as a surrogate endpoint significantly de-risks and accelerates Carvykti's path to broader approvals. LEGN's robust c [Read more]